Statement Of Cash Flows [Abstract]

Marinomed Biotech AG - Filing #1129987

Concept As at
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities
35,000 EUR
44,000 EUR
Cash flows from (used in) operating activities
6,885 EUR
7,641 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
3,964 EUR
2,376 EUR
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
787,000 EUR
984,000 EUR
Cash flows from (used in) financing activities
8,006 EUR
20,321 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
22,000 EUR
86,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
2,813 EUR
10,304 EUR
Cash and cash equivalents
9,207 EUR
12,020 EUR
1,716 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.